1264. Healthcare acquired influenza in critical ill patients
Session: Poster Abstract Session: Healthcare Epidemiology: Outbreaks
Friday, October 5, 2018
Room: S Poster Hall
Posters
  • 1264 Healthcare_influenza_critical_patient.pdf (316.7 kB)
  • Background: Healthcare-associated infections (HAIs) increases morbidity and mortality. During 2014, at Hospital Clínico Red de Salud UC CHRISTUS (RS-UCCH), was estimated that 15% of viral respiratory infections were acquired during hospitalization, and influenza was the main etiologic agent. The aim of this study was to obtain clinical characterization of HAIs due to influenza virus in patients hospitalized in critical care units (CCU) and special care units (chronic patients who need hospitalized nurse care).

    Methods: Descriptive study of CCU and special care patients with hospital acquired influenza during 2014-2017. HAI due to influenza was defined as: symptoms onset and/or positive influenza PCR ≥ 48 hours after hospital admission, without previous respiratory symptoms or with negative PCR.

    Results: 22 patients with median age of 74 years old were identified, only 3 pediatric cases. The average time of acquired influenza was at thirteenth day of hospitalization. In 77% Influenza A was the only agent detected and 27% had respiratory co-infection. Thirteen (59%) were previously hospitalized in CCU, but only 2 (15%) due to respiratory problems. Nineteen patients (86%) presented comorbidity such as arterial hypertension (59%), chronic kidney disease (18%) and immunosuppression (18%). Half of them had a decompensation, mainly respiratory, associated to influenza infection. The observed lethality was 18%. Among all the influenza HAI, 59% occurred in unvaccinated patients, although 46% of them met criteria for vaccination recommendation.

    Conclusion: HAI due to influenza occurred in chronic, older and unvaccinated patients. Education about HAIs and continuing high vaccination coverage must be a priority.

    Valentina Gutierrez, MD1, Jaime Cerda, MD2, Nicole Le Corre, MD, PHD3, Rafael Medina, PhD4 and Marcela Ferres, MD, MPH4, (1)Pediatric Infectious Diseases and Immunology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile, (2)Public Health, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile, (3)Pediatric Infectious Diseases and Immunology, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile, (4)Dpto De Enfermedades Infecciosas e Inmunología Pediátrica, Pontificia Universidad Católica de Chile, Santiago, Chile

    Disclosures:

    V. Gutierrez, None

    J. Cerda, None

    N. Le Corre, None

    R. Medina, None

    M. Ferres, None

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.